VANCOUVER, BC, CANADA & SAN DIEGO, CA, USA, Sept. 26 /CNW/ - MIGENIX Inc.
(TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious and
degenerative diseases, will make a presentation at the UBS 2006 Global Life
Sciences Conference being held in New York City September 25-28, 2006. Dr. Jim
DeMesa, President and Chief Executive Officer, will present a corporate
overview on September 28th at 11:30am (ET) in Ballroom A of the Grand Hyatt
New York. A webcast of the presentation will be available by registering at
www.ibb.ubs.com (click on "Conferences" box and then "Webcast" for the
September 25-28 conference) and a copy of the presentation will be available
on the Company's web site at www.migenix.com the day of the presentation.